Laurion Capital Management’s CareDx CDNA Stock Holding History

Laurion Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,621	Closed	-$631K	–	671
2020 Q3	$631K	Buy	16,621 +4,458	+37%	+$151K	0.01%	530
2020 Q2	$431K	Buy	+12,163	New	+$346K	﹤0.01%	649
2018 Q2	–	Sell	-37,218	Closed	-$297K	–	1349
2018 Q1	$297K	Buy	+37,218	New	+$229K	﹤0.01%	1135

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Laurion Capital Management's CDNA Position: Q4 2020 in Review

Laurion Capital Management sold out of CareDx (CDNA) in Q4 2020, closing a stake of 16,621 shares — an estimated $631K sold.

Laurion Capital Management first reported a position in CDNA in Q1 2018 and held it in 3 quarters. The position peaked at $631K in Q3 2020. 232 funds tracked by Wall St. Rank hold CDNA as of Q4 2020.

Laurion Capital Management reported no remaining CareDx position as of Q4 2020 after selling out during the quarter.
Laurion Capital Management sold 16,621 CareDx shares in Q4 2020, an estimated $631K.
Laurion Capital Management first reported a position in CareDx in Q1 2018 and held it in 3 quarters.
Laurion Capital Management's CareDx position peaked at $631K in Q3 2020.
232 funds tracked by Wall St. Rank held CareDx as of Q4 2020.

Based on Laurion Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.